Skip to main content
NIH funding notice PA-14-307

Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)

Closed on September 7, 2016.

Posted
August 4, 2014
Close date
September 7, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,031,348 in first-year total cost, median $290,999.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BST-F (10)]4
  2. Special Emphasis Panel[ZRG1 IDM-X (10)]2
  3. Special Emphasis Panel[ZRG1 IMST-J (15)]1

Most frequent institutions

  1. DIAVACS, INC.1
  2. ENBIOTIX, INC.1
  3. FANNIN PARTNERS, LLC1
  4. PDX PHARMACEUTICALS, INC.1
  5. STEM PHARM, INC.1
Competing awards under PA-14-307 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Development of topical formulation of siRNA-nanoparticle for treating skin diseases1R43TR001906-01A1NGAMCHERDTRAKUL, WORAPOLYANTASEE, WASSANAPDX PHARMACEUTICALS, INC., OR$325,000ZRG1
2017Reconstituted High Density Lipoprotein Particles as siRNA Carriers1R43TR002043-01CHATTERJEE, DEV KUMARFANNIN PARTNERS, LLC, TX$324,593ZRG1
2017CRISPR-Cas9 Systems Delivered by Targeted Nanoparticles to Eradicate Herpesvirus Pathogens1R43AI131958-01KRUG, LAURIE TSITHARAMAN, BALAJITHERAGNOSTIC TECHNOLOGIES, INC., NY$306,277ZRG1
2017Biomaterials for mRNA-based cellular reprogramming1R43TR001904-01LEBAKKEN, CONNIE SSTEM PHARM, INC., WI$290,999ZRG1
2016Engineered bacteriophage as a platform to deliver nucleic acid based therapeutics to bacteria to disperse biofilms in implant-associated infections such as prosthetic joint infections1R43AI126978-01RADDING, JEFFREY ALANENBIOTIX, INC., MA$263,500ZRG1
2016Antisense-Loaded Microsphere Therapy for Autoimmune Diseases1R43AI124783-01LEWIS, ALANDIAVACS, INC., CA$231,153ZRG1
2015Construction of bacteriophage nanoparticles for targeted delivery of nucleic acid therapeutics1R43TR001404-01PARSLEY, TODD BERNARDSYNPHAGEN, LLC, MD$289,826ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-14-307: Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) | ScienceDex | ConductScience